GW&K Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.8M | Sell |
|
|||||
|
2025
Q1 | $3.67M | Sell |
|
|||||
|
2024
Q4 | $3.77M | Sell |
|
|||||
|
2024
Q3 | $3.78M | Sell |
|
|||||
|
2024
Q2 | $3.29M | Sell |
|
|||||
|
2024
Q1 | $2.91M | Sell |
|
|||||
|
2023
Q4 | $3.95M | Buy |
|
|||||
|
2023
Q3 | $2.24M | Sell |
|
|||||
|
2023
Q2 | $2.75M | Sell |
|
|||||
|
2023
Q1 | $2.86M | Buy |
|
|||||
|
2022
Q4 | $2.01M | Sell |
|
|||||
|
2022
Q3 | $2.62M | Sell |
|
|||||
|
2022
Q2 | $3M | Sell |
|
|||||
|
2022
Q1 | $3.92M | Buy |
|
|||||
|
2021
Q4 | $3.94M | Buy |
|